Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 109

1.

Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndrome.

Jimenez-Vargas NN, Pattison LA, Zhao P, Lieu T, Latorre R, Jensen DD, Castro J, Aurelio L, Le GT, Flynn B, Herenbrink CK, Yeatman HR, Edgington-Mitchell L, Porter CJH, Halls ML, Canals M, Veldhuis NA, Poole DP, McLean P, Hicks GA, Scheff N, Chen E, Bhattacharya A, Schmidt BL, Brierley SM, Vanner SJ, Bunnett NW.

Proc Natl Acad Sci U S A. 2018 Jul 31;115(31):E7438-E7447. doi: 10.1073/pnas.1721891115. Epub 2018 Jul 16.

PMID:
30012612
2.

Anti-cancer and analgesic effects of resolvin D2 in oral squamous cell carcinoma.

Ye Y, Scheff NN, Bernabé D, Salvo E, Ono K, Liu C, Veeramachaneni R, Viet CT, Viet DT, Dolan JC, Schmidt BL.

Neuropharmacology. 2018 Sep 1;139:182-193. doi: 10.1016/j.neuropharm.2018.07.016. Epub 2018 Jul 20.

PMID:
30009833
3.

Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation.

Mulpuri Y, Marty VN, Munier JJ, Mackie K, Schmidt BL, Seltzman HH, Spigelman I.

Neuropharmacology. 2018 Sep 1;139:85-97. doi: 10.1016/j.neuropharm.2018.07.002. Epub 2018 Jul 5.

PMID:
29981335
4.

TNFα in the Trigeminal Nociceptive System Is Critical for Temporomandibular Joint Pain.

Bai Q, Liu S, Shu H, Tang Y, George S, Dong T, Schmidt BL, Tao F.

Mol Neurobiol. 2018 Apr 25. doi: 10.1007/s12035-018-1076-y. [Epub ahead of print]

PMID:
29696511
5.

Dental disease before radiotherapy in patients with head and neck cancer: Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients.

Brennan MT, Treister NS, Sollecito TP, Schmidt BL, Patton LL, Mohammadi K, Long Simpson L, Voelker H, Hodges JS, Lalla RV.

J Am Dent Assoc. 2017 Dec;148(12):868-877. doi: 10.1016/j.adaj.2017.09.011. Erratum in: J Am Dent Assoc. 2018 Feb;149(2):89.

PMID:
29173331
6.

Tumor necrosis factor alpha secreted from oral squamous cell carcinoma contributes to cancer pain and associated inflammation.

Scheff NN, Ye Y, Bhattacharya A, MacRae J, Hickman DN, Sharma AK, Dolan JC, Schmidt BL.

Pain. 2017 Dec;158(12):2396-2409. doi: 10.1097/j.pain.0000000000001044.

PMID:
28885456
7.

Cutaneous pigmentation modulates skin sensitivity via tyrosinase-dependent dopaminergic signalling.

Ono K, Viet CT, Ye Y, Dang D, Hitomi S, Toyono T, Inenaga K, Dolan JC, Schmidt BL.

Sci Rep. 2017 Aug 23;7(1):9181. doi: 10.1038/s41598-017-09682-4.

8.

Alterations in opioid inhibition cause widespread nociception but do not affect anxiety-like behavior in oral cancer mice.

Ye Y, Bernabé DG, Salvo E, Viet CT, Ono K, Dolan JC, Janal M, Aouizerat BE, Miaskowski C, Schmidt BL.

Neuroscience. 2017 Nov 5;363:50-61. doi: 10.1016/j.neuroscience.2017.06.038. Epub 2017 Jun 30.

PMID:
28673713
9.

OPRM1 Methylation Contributes to Opioid Tolerance in Cancer Patients.

Viet CT, Dang D, Aouizerat BE, Miaskowski C, Ye Y, Viet DT, Ono K, Schmidt BL.

J Pain. 2017 Sep;18(9):1046-1059. doi: 10.1016/j.jpain.2017.04.001. Epub 2017 Apr 27.

10.

Ex vivo nonviral gene delivery of μ-opioid receptor to attenuate cancer-induced pain.

Yamano S, Viet CT, Dang D, Dai J, Hanatani S, Takayama T, Kasai H, Imamura K, Campbell R, Ye Y, Dolan JC, Kwon WM, Schneider SD, Schmidt BL.

Pain. 2017 Feb;158(2):240-251. doi: 10.1097/j.pain.0000000000000750.

11.

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.

Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, Mennenga SE, Belser A, Kalliontzi K, Babb J, Su Z, Corby P, Schmidt BL.

J Psychopharmacol. 2016 Dec;30(12):1165-1180.

12.

Piphillin: Improved Prediction of Metagenomic Content by Direct Inference from Human Microbiomes.

Iwai S, Weinmaier T, Schmidt BL, Albertson DG, Poloso NJ, Dabbagh K, DeSantis TZ.

PLoS One. 2016 Nov 7;11(11):e0166104. doi: 10.1371/journal.pone.0166104. eCollection 2016.

13.

Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice.

Peterson DE, O'Shaughnessy JA, Rugo HS, Elad S, Schubert MM, Viet CT, Campbell-Baird C, Hronek J, Seery V, Divers J, Glaspy J, Schmidt BL, Meiller TF.

Cancer Med. 2016 Aug;5(8):1897-907. doi: 10.1002/cam4.761. Epub 2016 Jun 23. Review.

14.

Gene Expression Profiling of Evening Fatigue in Women Undergoing Chemotherapy for Breast Cancer.

Kober KM, Dunn L, Mastick J, Cooper B, Langford D, Melisko M, Venook A, Chen LM, Wright F, Hammer M, Schmidt BL, Levine J, Miaskowski C, Aouizerat BE.

Biol Res Nurs. 2016 Jul;18(4):370-85. doi: 10.1177/1099800416629209. Epub 2016 Mar 8.

15.

Structural and functional interactions between six-transmembrane μ-opioid receptors and β2-adrenoreceptors modulate opioid signaling.

Samoshkin A, Convertino M, Viet CT, Wieskopf JS, Kambur O, Marcovitz J, Patel P, Stone LS, Kalso E, Mogil JS, Schmidt BL, Maixner W, Dokholyan NV, Diatchenko L.

Sci Rep. 2015 Dec 11;5:18198. doi: 10.1038/srep18198.

16.

The Neurobiology of Cancer Pain.

Schmidt BL.

J Oral Maxillofac Surg. 2015 Dec;73(12 Suppl):S132-5. doi: 10.1016/j.joms.2015.04.045. Review.

17.

Differential Regulation of 6- and 7-Transmembrane Helix Variants of μ-Opioid Receptor in Response to Morphine Stimulation.

Convertino M, Samoshkin A, Viet CT, Gauthier J, Li Fraine SP, Sharif-Naeini R, Schmidt BL, Maixner W, Diatchenko L, Dokholyan NV.

PLoS One. 2015 Nov 10;10(11):e0142826. doi: 10.1371/journal.pone.0142826. eCollection 2015.

18.

Glycosylated Hemoglobin A1c and Lack of Association With Symptom Severity in Patients Undergoing Chemotherapy for Solid Tumors.

Hammer MJ, Aouizerat BE, Schmidt BL, Cartwright F, Wright F, Miaskowski C.

Oncol Nurs Forum. 2015 Nov;42(6):581-90. doi: 10.1188/15.ONF.581-590.

PMID:
26488828
19.

Trajectories of Evening Fatigue in Oncology Outpatients Receiving Chemotherapy.

Wright F, D'Eramo Melkus G, Hammer M, Schmidt BL, Knobf MT, Paul SM, Cartwright F, Mastick J, Cooper BA, Chen LM, Melisko M, Levine JD, Kober K, Aouizerat BE, Miaskowski C.

J Pain Symptom Manage. 2015 Aug;50(2):163-75. doi: 10.1016/j.jpainsymman.2015.02.015. Epub 2015 Mar 28.

20.

Predictors and Trajectories of Morning Fatigue Are Distinct From Evening Fatigue.

Wright F, D'Eramo Melkus G, Hammer M, Schmidt BL, Knobf MT, Paul SM, Cartwright F, Mastick J, Cooper BA, Chen LM, Melisko M, Levine JD, Kober K, Aouizerat BE, Miaskowski C.

J Pain Symptom Manage. 2015 Aug;50(2):176-89. doi: 10.1016/j.jpainsymman.2015.02.016. Epub 2015 Mar 28.

Supplemental Content

Loading ...
Support Center